EUVIMEDEUVIMED entdecken
Crossref

A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5

Aruba Cham

Journal of Cancer Treatment and Research · 2015

DOI: 10.11648/j.jctr.20150302.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Treatment and Research, 2015. Verfasst von Aruba Cham. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cham, A. (2015). A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research. https://doi.org/10.11648/j.jctr.20150302.12

Vancouver

Cham A. A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research. 2015. doi:10.11648/j.jctr.20150302.12

BibTeX
@article{Cham2015,
  author = {Cham, Aruba},
  title = {A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5},
  journal = {Journal of Cancer Treatment and Research},
  year = {2015},
  doi = {10.11648/j.jctr.20150302.12}
}
Kostenlos starten →